Stimulating TSH receptor autoantibodies immunoassay: analytical evaluation and clinical performance in Graves’ disease

Alfredo Pontecorvi, Cinzia Carrozza, Pietro Locantore, Cecilia Zuppi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

13 Citazioni (Scopus)

Abstract

Background Thyroid-stimulating hormone (TSH) receptor (TSHR) autoantibodies (TRAbs) are a heterogeneous group of antibodies (Abs) with different functionalities. Among all TRAbs, only the stimulating ones (S-TRAbs) are considered as the pathogenetic marker of Graves' disease (GD). To date, the methods available for TRAbs testing are based on immunoassays (IMAs) which detect total serum TRAbs or bioassays which are not suitable in clinical practice, even though they discern Abs functionality. The aim of our work was to evaluate the analytical and clinical performance of a very recent IMA (Immulite TSI method), supposed to test only the serum concentration of S-TRAbs, in comparison with a current method for total TRAbs (Roche/Elecsys IMA). Methods We evaluated serum samples of 145 subjects: 46 with untreated (GD), 36 with chronic autoimmune thyroiditis, 3 with atrophic thyroiditis, 10 with multinodular non-toxic goiter and 50 healthy subjects. Results The method showed an optimal analytical sensitivity and high precision levels (LoB: 0.04UI/L, LoD:0.07UI/L, LoQ:0.14UI/L, intra-assay CV: 4.2-5.9%, inter-assay: 4.5-7.2%). By receiver operating characteristics curve analysis, we obtained a value of 0.57 (sensitivity: 98.0%, specificity: 99.9%) as the best cut-off to distinguish GD, apart from four cases. Passing Bablok regression and Bland Altman analysis pointed out a good correlation and agreement with Roche method (R-2=0.98, slope=1.03, bias=-2.70). Conclusions The new method presents very promising analytical characteristics and could be adopted in clinical practice for GD diagnosis. Moreover, the test allows to accurately detect very low values of analyte with a further clinical utility in detecting earlier possible relapses.
Lingua originaleEnglish
pagine (da-a)172-177
Numero di pagine6
RivistaAnnals of Clinical Biochemistry
Volume55
DOI
Stato di pubblicazionePubblicato - 2018

Keywords

  • Article
  • Graves Disease
  • Graves disease
  • Graves’ disease
  • Hashimoto disease
  • Humans
  • Immunoassay
  • Receptors, Thyrotropin
  • S-TRAbs
  • Sensitivity and Specificity
  • antibody blood level
  • atrophic thyroiditis
  • autoantibody
  • blood analysis
  • controlled study
  • female
  • human
  • hyperthyroidism
  • immunoassay
  • immunology
  • major clinical study
  • male
  • nodular goiter
  • priority journal
  • procedures, Autoantibodies
  • sensitivity and specificity
  • thyroglobulin antibody
  • thyroid peroxidase antibody
  • thyroiditis
  • thyrotropin receptor antibody
  • thyrotropin receptor, adult
  • thyroxine

Fingerprint Entra nei temi di ricerca di 'Stimulating TSH receptor autoantibodies immunoassay: analytical evaluation and clinical performance in Graves’ disease'. Insieme formano una fingerprint unica.

Cita questo